PBA
Paradigm Biocapital Advisors’s Arvinas ARVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,339,961
| Closed | -$57.6M | – | 29 |
|
|
2024
Q3 | $57.6M | Sell |
2,339,961
-98,188
| -4% | -$2.42M | 1.95% | 15 |
|
|
2024
Q2 | $64.9M | Sell |
2,438,149
-176,786
| -7% | -$4.71M | 2.48% | 16 |
|
|
2024
Q1 | $108M | Buy |
2,614,935
+1,683,632
| +181% | +$69.5M | 3.8% | 9 |
|
|
2023
Q4 | $38.3M | Buy |
+931,303
| New | +$38.3M | 1.79% | 18 |
|
|
2023
Q1 | – | Sell |
-599,599
| Closed | -$20.5M | – | 27 |
|
|
2022
Q4 | $20.5M | Buy |
599,599
+315,822
| +111% | +$10.8M | 2.41% | 18 |
|
|
2022
Q3 | $12.6M | Sell |
283,777
-233,629
| -45% | -$10.4M | 1.68% | 18 |
|
|
2022
Q2 | $21.8M | Buy |
517,406
+26,073
| +5% | +$1.1M | 4.34% | 10 |
|
|
2022
Q1 | $33.1M | Buy |
491,333
+222,814
| +83% | +$15M | 8.74% | 3 |
|
|
2021
Q4 | $22.1M | Buy |
+268,519
| New | +$22.1M | 6.3% | 7 |
|